Cytotoxicity of Gold Complexes with Thiobenzoate
Author Information
Author(s): Beverly R. Vincent, David J. Clarke, Douglas R. Smyth, Dick de Vos, Edward R. T. Tiekink
Primary Institution: Molecular Structure Corporation
Hypothesis
The study investigates the cytotoxicity of triorganophosphinegold(I) complexes against various human cancer cell lines.
Conclusion
The gold-containing compounds exhibited good to high cytotoxicity but were not as active as cisplatin in all human cell lines.
Supporting Evidence
- The complexes showed moderate to high cytotoxicity with ID50 values ranging from 250 to 2500 ng/ml.
- The triphenylphosphine compound was uniformly more active than the cyclohexylphosphine compound.
- The known anti-tumor compound had comparable activity to one of the new complexes.
- The gold complexes were more active than cisplatin in some cancer cell lines.
Takeaway
The researchers tested new gold compounds to see if they could kill cancer cells, and found that some worked well but not as well as a common cancer drug called cisplatin.
Methodology
Cytotoxicity was evaluated using the microculture sulforhodamine B (SRB) test on seven human cancer cell lines.
Limitations
The study did not report full details on the structure of one of the complexes due to high residual electron density peaks.
Participant Demographics
The study involved seven human cancer cell lines, including breast, colon, ovarian, melanoma, renal, and lung cancers.
Want to read the original?
Access the complete publication on the publisher's website